(Q34993317)

5 August 2017

1 reference

title

Osteoporosis in elderly: prevention and treatment (English)

1 reference

5 August 2017

0 references

Manish Srivastava

1

1 reference

PubMed ID

12424871

5 August 2017

Chad Deal

series ordinal

2

1 reference

5 August 2017

1 August 2002

1 reference

Clinics in geriatric medicine

5 August 2017

1 reference

5 August 2017

18

1 reference

5 August 2017

3

1 reference

5 August 2017

529-555

1 reference

The diagnosis of osteoporosis

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Prevalence of low femoral bone density in older U.S. women from NHANES III

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Hip fracture incidence among the old and very old: a population-based study of 745,435 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Hip fractures: a worldwide problem today and tomorrow

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Hip fractures in the elderly: a world-wide projection

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Epidemiology of hip fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The aging of America. Impact on health care costs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Epidemiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Epidemiology of osteoporosis in the United States of America

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Vertebral fracture epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The epidemiology of peripheral fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Incidence of Colles' fracture in Uppsala. A prospective study of a quarter-million population

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Osteoporotic fractures of the proximal humerus in elderly Finnish persons: sharp increase in 1970-1998 and alarming projections for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Population-based study of survival after osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Clinical outcomes and mortality after hip fracture: a 2-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The association of radiographically detected vertebral fractures with back pain and function: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The clinical consequences of vertebral compression fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

A clinical profile of back pain and disability in patients with spinal osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Association of osteoporotic vertebral compression fractures with impaired functional status

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Vertebral fracture and other predictors of physical impairment and health care utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The clinical impact of vertebral fractures: quality of life in women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Impact of a 12-month exercise program on the physical and psychological health of osteopenic women.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Weight-training effects on bone mineral density in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Correcting calcium nutritional deficiency prevents spine fractures in elderly women.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Calcium Supplementation Prevents Seasonal Bone Loss and Changes in Biochemical Markers of Bone Turnover in Elderly New England Women: A Randomized Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Annual injection of vitamin D and fractures of aged bones.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

An open-label extension study of alendronate treatment in elderly women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Upper gastrointestinal toxicity of alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effects of alendronate on gastric and duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Prevention of spinal osteoporosis in oophorectomised women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Osteoporosis prevention and treatment with sex hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Do estrogens improve bone mineral density in osteoporotic women over age 65?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

The effect of postmenopausal estrogen therapy on bone density in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Variation in the Efficacy of Hormone Replacement Therapy in the Prevention of Hip Fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of salcatonin given intranasally on early postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

What PROOF proves about calcitonin and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Phytoestrogens and bone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Ipriflavone in the Treatment of Postmenopausal OsteoporosisA Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Risk factors for osteoporotic fractures in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Lack of association between free testosterone and bone density separate from age in elderly males

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Bone mineral density and androgen levels in elderly males

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

1 reference

7 January 2021

Alendronate for the Treatment of Osteoporosis in Men

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Therapeutic role of androgens in the treatment of osteoporosis in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

1 reference

7 January 2021

Hip fractures in Finland between 1970 and 1997 and predictions for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

Clinical use of biochemical markers of bone remodeling: current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900022-8

1 reference

7 January 2021

10.1016/S0749-0690(02)00022-8

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12424871